Pamela Cardenas

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study

Bryan Williams, John R. Cockcroft, Kazuomi Kario et al. · BMJ Open · 2014 · 51 citations · Full text

Medicine, Cardiology, Pharmacology +17

Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial

Fernando J. Martínez, Gerard J. Criner, Margret Jandl et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 45 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)

Mario Castro, Edward Kerwin, David Miller et al. · EClinicalMedicine · 2021 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy

Yuan-nan Ke, Dingliang Zhu, Huashan Hong et al. · Current Medical Research and Opinion · 2010 · 28 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

A clinical trial evaluating the 24‐hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension

Andrew Lewin, Mark C. Lueg, Shari Targum et al. · Clinical Cardiology · 1993 · 14 citations

Pharmacy, Pharmacology, Pharmacotherapy +17